The serum heavy/light chain immunoassay: a valuable tool for sensitive paraprotein assessment, risk and disease monitoring in monoclonal gammopathies

ConclusionsDespite the fact that different PCD patients were included, the assessment of the HLC‐immunoassay in MGUS, SMM, MM and WM, our comparison with standard mp‐assays, and relevant PFS differences may excite future applications, which should be confirmed in prospective multicenter trials.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - Category: Hematology Authors: Tags: Original Article Source Type: research